BioCentury
ARTICLE | Clinical News

Astenose: Filed IND to conduct Phase I trials

February 7, 1994 8:00 AM UTC

Glycomed Inc. (GLYC), Alameda, Calif. Product: Astenose, modified heparin Indication: Prevent restenosis after angioplasty or vascular surgery Status: Filed IND to conduct Phase I trials in healthy v...